Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes

Diabetes Technology& Therapeutics Feb 2018, Vol. 20, No. 2: 160-170.

Source: Diabetes Technology - January 23, 2018 Category: Endocrinology Authors: Philip Home Karl-Michael Derwahl Monika Ziemen Karin Wernicke-Panten Suzanne Pierre Yvonne Kirchhein Satish K. Garg Source Type: research